Company intelligence / Profile preview

Onnit

Austin, Texas, United Statesonnit.com ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Onnit’s flagship supplement Alpha BRAIN® has been marketed as a nootropic for improved memory, focus, and mental processing. The company offers a broad range of commercialized dietary supplements for cognitive function, mood/relaxation, gut health/immunity support as well as functional foods and fitness equipment. No clinical trial data or regulatory drug development programs are reported.

Therapeutic areas: ImmunologyOtherPsychiatryGastroenterologyNeurology
Modalities: Small molecule (nutritional supplements)Functional food productsDevice (fitness equipment)
Industry: Food & Nutrition

Drug pipeline

1 asset

Alpha BRAIN

Commercial

Indications: Cognitive enhancement, Memory, Mental focus

Beyond the preview

Go deeper on Onnit.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Onnit.

Explore the full profile